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Abbreviations and acronyms: 2OG, 2-oxoglutarate; FIH, Factor Inhibiting HIF; H3, histone 3; HIF, Hypoxia Inducible Factor;
JmjC, Jumonji C-terminal; JmjN, Jumonji N-terminal; KDM, Lysine Demethylase; LSD, Lysine Specific Demethylase;
MALDI-TOF MS, Matrix Assisted Laser Desorption/Ionization Time of Flight Mass Spectrometry; MINA53, Myc-Induced Nuclear
Antigen with a molecular mass of 53 kDa; NO66, Nucleolar protein 66; PHD, Plant Homeodomain; Rp, Ribosomal protein; TPR,
Tetratricopeptide repeat
The JmjC-domain-containing 2-oxoglutarate-dependent oxygenases catalyze protein hydroxylation and Ne-
methyllysine demethylation via hydroxylation. A subgroup of this family, the JmjC lysine demethylases (JmjC KDMs) are
involved in histone modifications at multiple sites. There are conflicting reports as to the substrate selectivity of some
JmjC oxygenases with respect to KDM activities. In this study, a panel of modified histone H3 peptides was tested for
demethylation against 15 human JmjC-domain-containing proteins. The results largely confirmed known Ne-
methyllysine substrates. However, the purified KDM4 catalytic domains showed greater substrate promiscuity than
previously reported (i.e., KDM4A was observed to catalyze demethylation at H3K27 as well as H3K9/K36).
Crystallographic analyses revealed that the Ne-methyllysine of an H3K27me3 peptide binds similarly to Ne-methyllysines of
H3K9me3/H3K36me3 with KDM4A. A subgroup of JmjC proteins known to catalyze hydroxylation did not display
demethylation activity. Overall, the results reveal that the catalytic domains of the KDM4 enzymes may be less selective than
previously identified. They also draw a distinction between the Ne-methyllysine demethylation and hydroxylation activities
within the JmjC subfamily. These results will be of use to thoseworking on functional studies of the JmjC enzymes.
Introduction
Post-oligomerization modifications to the nucleic acid and
protein components of chromatin play central roles in transcrip-
tional regulation. While DNA methylation is associated with
gene silencing, methylation of histone proteins can be activating
or repressive depending on the context of the modification.1 The
introduced methyl groups can undergo further modification,
often by oxidation; the largest identified class of such enzymes
are the Fe(II)- and 2-oxoglutarate- (2OG) dependent oxygenases,
which catalyze oxidation of 5-methylcytosine bases, and of
N-methyl groups in DNA (and RNA) and histone proteins.2
Two families of Ne-methyllysine demethylases (KDMs) have
been identified: the Fe(II)- and 2OG-dependent JmjC KDMs
(Fig. 1A) and the flavin-dependent lysine specific demethylases
(KDM1s or LSDs).3 JmjC KDMs act on all 3 Ne-methyllysine
methylation states (Fig. 1B), whereas the KDM1s can only act
on di- and mono-methylation states. The JmjC KDMs are part
of the wider JmjC subfamily of 2OG oxygenases, which also cata-
lyze protein hydroxylation not involving demethylation.4 For
several JmjC enzymes, (JMJD6, MINA53 and NO66), there are
reports of both demethylation and hydroxylation activities.4-9
Substrate promiscuity is well-established in 2OG oxygenase bio-
chemistry, including for the JmjC hydroxylase factor inhibiting
hypoxia inducible factor (FIH), which catalyzes hydroxylation of
an asparaginyl residue in Hypoxia Inducible Factor a (HIF-a) as
well as multiple asparagine-, aspartate- and histidine-residues in
ankyrin repeat-domain proteins.10-13 Given the different reports
of the reactions catalyzed by some JmjC oxygenases, we consid-
ered that it would be useful to carry out a systematic study on the
biochemical selectivity of the catalytic domains of human JmjC
KDMs. We appreciate that other factors, for example, ancillary
non-catalytic domains, targeting proteins, protein conformation,
co-substrate and inhibitor availability, substrate length (peptide/
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protein), and cellular compartmentalization, may alter hydroxyl-
ation and demethylation catalysis and substrate selectivities in a
cellular context. However, these results provide an in vitro
comparative substrate profiling of JmjC oxygenases that will be
useful to other researchers in the field.
In general, the results with JmjC KDMs support the reported
selectivities,14-20 as well as current structural studies,21 which
show that JmjC KDMs and hydroxylases are different subfamilies
within the 2OG oxygenase family, with little overlap in hydroxyl-
ation and demethylation activities. However, we observed that
the KDM4 subfamily catalytic domains could not only catalyze
demethylation of H3 peptides methylated at K9 and K36, but
also at K27, implying that the selectivities of the JmjC KDMs
may extend beyond the already characterized substrates.
Results
To compare the selectivities of the catalytic domains of the
JmjC oxygenases we screened a set of H3 peptides (either from
Alta Bioscience, or synthesized in house) with the isolated cata-
lytic domains of 15 JmjC oxygenases using MALDI-TOF Mass
Spectrometry (MS, Table 1). The enzymes were chosen to repre-
sent different subfamilies of JmjC oxygenases (Fig. 1A) and based
on the availability of active recombinant proteins.22 The H3 frag-
ment peptides screened were 21 residues in length and included
mono-, di-, and tri-methyllysines at K4, K9, K27, and K36 sites
(Table S1). Standard conditions of 1 mM enzyme, 200 mM
2OG, 10 mM Fe(II) and 100 mM ascorbate were used through-
out (i.e., large excesses of cofactors and substrates),23 but the
assay buffer conditions were optimized to enhance activity and
MS signal, as well as to reduce protein precipitation (Table S2).
The results with the catalytic domains of KDM2A, KDM3A,
KDM5C, KDM6A, and KDM6B support literature assign-
ments.15,16,18,19,24-28 Thus, under standard conditions, and as
summarized in Table 1, (i) KDM2A only accepted H3K36me2
and H3K36me1 (Figure S1), (ii) KDM3A accepted H3K9me2
and H3K9me1 (Figure S2), (iii) KDM5C accepted H3K4me3,
H3K4me2, and H3K4me1 (Figure S3), and (iv) KDM6B acted
on H3K27me3, H3K27me2 and H3K27me1, while KDM6A
acted (under our conditions) on H3K27me3 and H3K27me2,
but not H3K27me1 (Figure S4). The latter result is consistent
with previous reports which demonstrate that the tetratricopep-
tide repeat (TPR) domain of KDM6A is required for effective
H3K27me1 demethylation, possibly by promoting enhanced
substrate binding.16 KDM7A is reported to catalyze the demeth-
ylation of di- and mono-methylated forms of both H3K9 and
H3K27 in the absence of substrate methylation at H3K4
(H3K4me3), but only at H3K27 when H3K4 is trimethylated
(i.e., H3K4 methylation promotes demethylation at
H3K27).29,30 We observed the same substrate selectivity for pepti-
des not methylated at H3K4 with our construct of KDM7A,
which contains both the JmjC and PHD domains (Figure S5, S6).
In the case of the tested JmjC oxygenases assigned as hydroxy-
lases (FIH and the recently reassigned NO66 and
MINA53),4,12,13 no KDM activity was observed with any of the
tested H3 peptides under our assay conditions (Figs. 2B, D, E,
S7, S8). This is of note as NO66 and MINA53 were initially
characterized as histone demethylases.8,9 Recent work, however,
Figure 1. JmjC Oxygenases share sequence homology and catalytic
mechanisms. (A) Phylogenetic analysis of the catalytic domains of
human JmjC oxygenases. Reported catalytic functions are indicated by
colored circles. MINA53, NO66 and JMJD6 have been reported to be
demethylases but have subsequently been shown to have hydroxylase
activities.4-6,8,9 KDM6C (UTY) was recently identified as a histone deme-
thylase in vitro, acting on H3 peptide fragments methylated at H3K27.43
HR is Hairless Protein, a recently identified H3K9 demethylase.44 Enzymes
used in this work are underlined. (B) Outline mechanism of JmjC oxygen-
ase catalysis. Oxidative decarboxylation of 2-oxoglutarate (2OG) in the
active site forms a highly reactive iron(IV)-oxo intermediate, which
hydroxylates the substrate. In the case of demethylation (X D N), the
hydroxylated product is unstable and fragments to produce the deme-
thylated species and formaldehyde. The exact protonation states of
water molecules complexed to the iron(II) species are unknown.
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has shown MINA53 and NO66 to be histidyl-hydroxylases act-
ing on the ribosomal proteins Rpl27a and Rpl8, respectively.31
In positive controls, we found these reported non-histone peptide
substrates to be hydroxylated by MINA53 and NO66 (Figs. 2A,
C). JMJD5 has also been reported to act as an H3K36me2 deme-
thylase;7 however, under our assay conditions, JMJD5-catalyzed
demethylation of H3K36me2 peptide was not observed
(Figs. 2F, 2G, S10).
In the case of the KDM4 subfamily, initial screening results
with KDM4A suggested that they may be more promiscuous
than reported (Table 1, Figure 3A, B, Figure S11);14 hence, we
analyzed all 4 human KDM4 subfamily members (KDM4A-D)
and the human pseudogene KDM4E (Table 1, Figures S11–
15). As reported, all the KDM4 members acted on H3K9me3
and H3K9me2, although we only observed clear demethylation
of H3K9me1 to the H3K9me0 state by KDM4E (although not
apparent under the standard conditions, prolonged incubations
with KDM4 enzymes leads to demethylation of H3K9me1)
(Figure S15).14 Also, as reported, KDM4A-C catalyzed
demethylation of H3K36me3/H3K36me2 but KDM4D/E did
not (Figure S14–S15).14 Surprisingly, most KDM4 catalytic
domains also acted on H3K27me3 and in one cases
H3K27me2 (Figures S11–15).
To investigate the unexpected results with respect to KDM4
selectivity, kinetic analyses were then undertaken using the
KDM4A catalytic domain (Fig. 3E, S16). The H3K9me3 and
H3K36me3 modified peptides had similar kcat values (kcat D
0.145 s¡1 and 0.166 s¡1, respectively), but H3K9me3 mani-
fested the highest kcat/Km (0.004393 s
¡1.mM¡1 for H3K9me3
and 0.001161 s¡1.mM¡1 for H3K36me3), consistent with previ-
ous reports.32,33 The H3K27me3 peptide was a poorer substrate
than both the H3K9me3 and H3K36me3 peptides but still dis-
played substantial activity (kcat D 0.031 s¡1). As anticipated, the
Km value was lowest for H3K9me3 (Km D 33 mM) followed by
H3K36me3 (Km D 143 mM). Competition experiments, moni-
toring demethylation of 2 equimolar peptides simultaneously,
support the reduced demethylation efficiency of KDM4A toward
H3K27me3 relative to H3K9me3/H3K36me3 (Figure S17).
The majority of H3K9me3 and H3K36me3 peptides were deme-
thylated to the monomethyllysine state before demethylation of
H3K27me3 was observed.
To investigate the mode of KDM4A binding to the
H3K27me3 substrate, we solved crystal structures of the
KDM4A catalytic domain complexed with both 25 residue and
5 residue H3K27me3 peptides (Figs. 4, S18, S19). In both cases,
the H3K27me3 residue was observed to bind in a near identical
manner to both H3K9me3 and H3K36me3 residues in H3 pep-
tides, supporting the proposed activity at H3K27me3 (Figs. 4,
S18). Notably, in the longer 25 residue H3K27me3 peptide
complex, density was observed for the trimethyllysine and the 2
adjacent peptide residues (H3R26 and H3S28 respectively), but
not for the other residues, while density was observed for all resi-
dues of the shorter 5 residue H3K27me3 peptide (Figure S19).
The lack of observed density for the longer peptide may reflect
relatively weaker binding relative of the H3K27me3 compared to
the H3K9me3 and H3K36me3 peptides, consistent with the
kinetic results (Figs. 3E, S16).
To investigate whether KDM4A promiscuity is a result of using
truncated protein (i.e., constructs containing only the catalytic
domain), we used immunoprecipitated FLAG-tagged full-length
recombinant KDM4A (which contains JmjN, JmjC, double PHD
and tandem tudor domains, Figure S5) exogenously over-expressed
Table 1. Summary of initial activity screening of JmjC oxygenases and methylated histone H3 fragment peptides. KDM activity (i.e., greater than 10% sub-
strate demethylation as detected by MALDI mass spectrometry) was observed for all tested members of the KDM enzymes (ticks), including at reported
methylation sites (green boxes) and, in the case of the KDM4 enzymes, at novel methylation sites (yellow boxes). No demethylation activity within limits of
detection was observed for the putative demethylases MINA53, NO66 or JMJD5 (crosses, red boxes; note for JMJD5 construct-dependent demethylation
activity is reported by Hsia et al (dashed red box) 7), while hydroxylation of reported non-histone substrates were observed for MINA53 and NO66 For
JMJD5, prime substrate uncoupled 2OG turnover was observed indicating active construct (ticks, green boxes). In some cases, demethylation of the me2/1
state (to the me1/0 state respectively) was only observed when the me2/1 peptide was produced as an intermediate during demethylation of the me3/2
state (dashed green/yellow boxes)
H3K4 H3K9 H3K27 H3K36
Subfamily Enzyme me3 me2 me1 me3 me2 me1 me3 me2 me1 me3 me2 me1 Activity
KDM2 2A1–517 x x x x x x x x x x @ @
KDM3 3A515–1317 x x x x @ @ x x x x x x
KDM4 4A1–359 x x x @ @ x @ @ x @ @ x
4B1–365 x x x @ @ x @ x x @ @ x
4C1–366 x x x @ @ x @ @ x @ @ x
4D1–358 x x x @ @ x x x x x x x
4E1–337 x x x @ @ @ @ @ x x x x
KDM5 5C1–765 @ @ @ x x x x x x x x x
KDM6 6A940–1401 x x x x x x @ @ x x x x
6B1141–1590 x x x x x x @ @ @ x x x
KDM7 7A38–480 x x x x @ @ x @ @ x x x
Hydrox. MINA5326–465 x x x x x x x x x x x x @
NO66116–641 x x x x x x x x x x x x @
JMJD51–416 x x x x x x x x x x x x @
FIH1–348 x x x x x x x x x x x x @
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in HEK 293T cells and tested for demethylation activity. The full-
length KDM4A catalyzed demethylation of H3K9me3, K36me3
and K27me3 (Fig. 3C, D).
Discussion
Overall, the results support most of the reported substrate selectiv-
ities for the catalytic domains of the JmjC KDMs.15,16,18,19,24-29 It is
important to note that in cases of apparent discrepancies with the lit-
erature, these may reflect the use of different constructs and/or condi-
tions and, in some cases, may arise from the omission of non-
catalytic domains that would otherwise alter substrate selectivity (e.g.,
a TPR domain in KDM6A increases activity toward H3K27me1).29
Nonetheless, given that in some
cases conflicting reports already
exist in the literature, we hope
that our results will provoke fur-
ther substrate profiling work for
KDMs in vitro and in cells.
Within the subset of 6 ‘well-char-
acterized’ subfamilies of JmjC
KDMs, our results were support-
ive of the literature, except for the
KDM4 subfamily. In the case of
this subfamily, where we studied
the catalytic domains of 5
KDM4s, we observed clear evi-
dence for demethylation of
H3K27me3/2 peptides. The
full-length KDM4A was also
able to catalyze demethylation at
H3K27me3/me2. Interestingly,
weak demethylase activity toward
H3K27me3 was previously
reported for recombinant mouse
KDM4s.34 We emphasize that,
based on our studies alone, we
cannot propose that the observed
KDM activity against
H3K27me3/2 is of ‘biological
relevance’. Nonetheless, given
the promiscuity of some other
2OG oxygenases acting on pro-
teins (e.g., FIH),10,11,35 there is
clear potential for KDM4 sub-
family members to act on
H3K27me3/2 or indeed other
presently unidentified substrates.
We did not observe any
KDM activity with the JmjC
oxygenases for which we have
observed hydroxylase activity
(i.e., the JmjC enzymes FIH,
MINA53 and NO66) or
JMJD5. From a physiological/
evolutionary perspective, this is unsurprising because they belong
to a different subfamily from the canonical JmjC KDMs
(Fig. 1A).21 However, we do not rule out the possibility that the
JmjC hydroxylases can act as KDMs; as indicated above, some
2OG oxygenases can be very promiscuous with regard to both
their in vitro and in vivo substrates. As we have found with FIH,
results with isolated proteins do not always predict cellular sub-
strate selectivities and vice versa.
Materials and methods
Protein production Catalytic domains of KDM2A,36
KDM4A-E,33,37,38 KDM6B,39 KDM7A,39 NO66,31
Figure 2. JmjC Oxygenases MINA53, NO66 and JMJD5 do not catalyze demethylation of histone peptides.
In addition to putative demethylation activities, MINA53 and NO66 have been characterized as hydroxylases act-
ing on ribosomal proteins Rpl27a and Rpl8 respectively. Hydroxylation activities were observed for MINA53 and
NO66, acting on Rpl27a and Rpl8 peptide fragments respectively (A and C); no demethylation was observed
with methylated histone peptides (B, D and E). Prime-substrate uncoupled turnover of 2OG by JMJD5 (residues
1–416) was observed in a [14C]-labeled 2OG assay, which was dependent on the presence of iron(II) and inhibited
by the broad-spectrum 2OG oxygenase inhibitor 2,4-pyridinedicarboxylic acid (2,4 PDA) (F). However, demethyla-
tion of an H3K36me2 histone peptide was not observed (G). Control reactions without added protein are in red.
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MINA5331, and FIH40 were
produced in, and purified
from E. coli as previously
described. KDM3A and
KDM5C were expressed and
purified from Sf9 cells as
described.39 JMJD5(1–416)
in pET28a(C) (Novagen) was
transformed into Rosetta DE3
E. coli and grown in 2 £ TY
media. Cells were induced at
mid log phase (OD600 D 0.6)
with 0.5 mM IPTG and
grown for a further 18 hours
at 25C and harvested by cen-
trifugation. The pellet was
resuspended in 50 mM
HEPES pH 7.5, 500 mM
NaCl, 5 mM imidazole and
5% glycerol with an EDTA-
free protease inhibitor tablet
(Roche). Cells were lysed by
sonication and the lysate clari-
fied by high speed centrifuga-
tion. Lysate was purified by
application to a HisTrapTM
HP 5 mL column (GEHealth-
care). The Ni-Sepharose col-
umn was washed with 20
column volumes of 50 mM
HEPES pH 7.5, 500 mM
NaCl, 20 mM imidazole and
5% glycerol, eluting with a
gradient up to 250 mM imid-
azole over 10 column volumes.
Fractions containing JMJD5
were concentrated and applied
to a 300 mL Superdex 75
prep grade column pre-equili-
brated in 50 mM HEPES pH
7.5, 500 mM NaCl, 1 mM
DTT and 5% glycerol.
Enzyme activity was assessed
by 2OG turnover assay
(Fig. S13).
2OG turnover radioactiv-
ity assay Recombinant JMJD5
was tested for ability to decarboxylate 1-[14C]-labeled 2OG, as
described for other 2OG oxygenases.13 Reactions (100 mL) con-
tained 4 mM sodium ascorbate, 0.288 mM 2OG, 0.0036 mM
[14C]-2OG, 0.005 mM Fe(II), 1mM DTT, 2% catalase, 40 mM
JMJD5, (10 mM inhibitor) in 50 mM HEPES pH 7.5. [14C]-
CO2 radioactivity was recorded using a Beckman LS4500 liquid
scintillation counter. Data shown (Fig. 2F) are mean values from
one assay performed in triplicate. Error bars give standard error
of mean.
Peptide Synthesis 21-mer H3 fragment peptides trimethy-
lated at positions K4, K9, K27 and K36 were synthesized via flu-
orenylmethyloxycarbonyl (Fmoc)-mediated solid phase peptide
synthesis (on MBHA resin) using a CS Bio 336X peptide synthe-
sizer. Peptides were cleaved from the resin using 97.5% trifluoro-
acetic acid / 2.5% triisopropylsilane solution (3 hr incubation)
before precipitation with cold diethyl ether. Peptides were puri-
fied by reverse-phase high-performance liquid chromatography
using a Vydac C18 column (Solvent A D 0.1% trifluoroacetic
Figure 3. KDM4A catalyzes demethylation of histone fragment peptides methylated at H3K27. MALDI-TOF
spectra of KDM4A (1–359) catalyzed demethylation of (A) H3K27me3 peptide (Biotin-Ahx(aminohexanoic acid)-
KAPRKQLATKAARKme3SAPATGG), (B) H3K9me3 peptide (Biotin-Ahx-ARTKQTARKme3STGGKAPRKQLA). MALDI-
TOF spectra of full-length KDM4A (1–1064) catalyzed demethylation of (C) H3K27me3 peptide (KAPRKQLAT-
KAARKme3SAPATGG) and (D) H3K9me3 peptide (Biotin-Ahx-ARTKQTARKme3STGGKAPRKQLA). FLAG-tagged
full-length KDM4A (1–1064) was produced in HEK293T cells and purified from cell lysates using anti-FLAG beads
prior to reaction with the histone peptide. MALDI-TOF spectra of reactions with (standard conditions, black) and
without added enzyme (red) for (A)–(D) are shown. (E) Kinetic parameters determined for KDM4A (1–359) cata-
lyzed demethylation of Ne-trimethylated H3K9, H3K27 and H3K36 fragment peptides using FDH assay
(Figure S16).
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acid in H2O, Solvent B D 0.1% trifluoroacetic acid in acetoni-
trile) to >95% purity as determined by MS.
MALDI-TOF activity assays Demethylation activities on
peptides were measured by Matrix-assisted laser-desorption/ioni-
zation (MALDI) time-of-flight (TOF) mass spectrometry (MS),
using a Waters Micromass MALDI micro MXTM mass spec-
trometer in negative ion, reflectron mode. Reaction conditions
varied between enzymes as optimized for each reaction
(Table S2). Concentrations of 2OG used were maintained above
the Km values for each enzyme. All reactions used 1 mM enzyme,
10 mM peptide, 2-oxoglutarate (2OG), FeSO4.7H2O and
sodium ascorbate. Reactions were incubated for 60–120 min at
37C, and were quenched with 1:2 MeOH by volume. An
aliquot of the quenched reaction (1 mL) was mixed with 1 mL
a-cyano-4-hydroxycinnamic acid (CHCA) matrix (Sigma) and
spotted on a MALDI-TOF plate for analysis.
MALDI competition assays Reaction conditions for competi-
tion assays were as for MALDI-TOF activity assays, but included
2 histone peptides (10 mM each). Reactions were initiated by
mixing the samples before incubation at room temperature. At
each time point, 5 mL of the reaction mixture was removed,
quenched with a 1:2 ratio of sample to MeOH and snap frozen
in liquid nitrogen. The zero time point was quenched prior to
addition of enzyme.
Formaldehyde Dehydrogenase (FDH) Assays Production of
formaldehyde as a by-product of demethylation was observed
using the FDH/NADC coupled assay.41 Assays contained buffer
(50 mM HEPES pH 7.5, 0.01% Tween20), Fe(II) ammonium
sulfate (10 mM), sodium ascorbate (100 mM), 2OG (200 mM),
NADC (500 mM), enzyme (0.2–2 mM) with FDH enzyme
(0.025 U, Sigma) per assay (total volume 25 mL) and were con-
ducted at room temperature in clear-bottom black 384-well plate
(Greiner). Reactions were monitored over 30 min using a
PHERAstar FS (BMG Labtech) plate reader with 355 nm excita-
tion and 460 nm emission. The Km and Vmax values were calcu-
lated from the reaction rate during the linear phase of
formaldehyde production, as determined by the slope of the fluo-
rescence signal recorded.
Cell culture HEK 293T cells were cultured at 37C with 5%
CO2 in DMEM (Sigma) supplemented with 10% fetal bovine
serum (FBS, Invitrogen) and 1% Glutamax (Invitrogen). Full
length KDM4A with FLAGx3 tag in pCDNA3 (kindly provided
by Yi Zhang42) was transiently transfected into HEK293T using
Fugene (50 mg DNA, 90 uL PEI per 15 cm diameter plate, 80%
confluency, PAA Laboratories) and harvested after 24 hr. Cells
were washed in PBS, lysed in 50 mM HEPES, 150 mM NaCl,
0.01% NP40, 1% protease inhibitor cocktail (SIGMA), DNAse
(10 mg/ml) and incubated with 60 mL FLAG-Magnetic Beads
(SIGMA) for 4 hr at 4C. Beads were washed 4 times with lysis
buffer (600 mL), 2 times with 50 mM HEPES (300 mL) to
remove NP40 and NaCl before MS analysis. Beads were re-sus-
pended in an initial volume of 60 mL for use in further assays.
Demethylation reactions were conducted with 1 mL of the
immobilized anti-FLAG beads with peptide (10 mM), 2OG
(200 mM), FeSO4.7H2O (10 mM), sodium ascorbate
(100 mM). Reactions were incubated for 120 min at 37C and
quenched with 1:2 MeOH by volume. The demethylation prod-
ucts were observed by MALDI.
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Figure 4. View from an X-ray crystal structure of the catalytic domain of
KDM4A in complex with an H3K27me3 fragment peptide (PDB ID:
4V2W). The active site residues are highlighted in yellow. The visible resi-
dues of the 25mer H310–35K27me3 (green) peptide is shown overlaid
with H3K9me3 (pink), as complexed with KDM4A (PDB ID: 2OQ6, nickel
substituted for iron, and N-oxalylglycine substituted for 2OG). The posi-
tion of the H3K27me3 residue of the fragment peptide correlates closely
with that of H3K9me3 (and H3K36me3, Figure S18). However, in the
H310–25K27me3 derived structure only the electron density for the tri-
methyl lysine and the residues either side (H3R26 and H3S28) are clearly
defined, suggesting the other residues are bound less tightly than the
comparable H3K9 and H3K36 substrates. A second structure of a shorter
5 residue H325–29K27me3 peptide in complex with KDM4A (PDB ID:
4V2V) overlays well with that of the 25 residue peptide (Figure S19). The
sequences for the H3K9, K27 and K36 peptides present in these crystal
structures are included with residues for which electron density is
observed in italics. The red lysine residue marks the position of the Ne-tri-
methylated lysine.
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